Power Wheelchair Group 3 denied as duplicate or overlapping therapy by UnitedHealthcare?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What UnitedHealthcare typically requires
UnitedHealthcare's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The UnitedHealthcare angle on Power Wheelchair Group 3
## Why UnitedHealthcare Denies Power Wheelchair (Group 3) as Duplicate Therapy
A duplicate-therapy denial means UHC's system has flagged that you already have an active benefit or recently received coverage for a power mobility device. Insurers apply this logic to prevent simultaneous or back-to-back approvals for equipment they consider functionally equivalent. In practice, this denial fires when there is an existing power wheelchair on record, a rental period has not yet concluded, or a prior device was replaced within a look-back window UHC defines in its own Medicare Advantage or commercial coverage policy.
This denial is frequently worth appealing because the circumstances behind the request are often meaningfully different: clinical progression may have changed your mobility needs, the prior device may have been lost, stolen, or rendered non-functional, or your treating physician may have prescribed a different class of Group 3 complex rehabilitation technology (CRT) than the device already on record.
## Your Federal Appeal Rights
You have layered federal protections. Under ERISA §503 (self-funded plans), you are entitled to a full-and-fair review of the denial. Under the ACA §2719 framework (fully insured and most employer plans), you may escalate to an independent external review after exhausting internal appeals. The external-review window is typically around four months from the date of denial notice — do not wait. If your condition is deteriorating and delays could cause serious harm, you may request expedited review, which carries a shorter decision timeline.
## What to Gather Before You Write Your Appeal
- Clinical history of the prior device: dates of delivery, reason it no longer meets current needs, or documentation of loss/damage/irreparable malfunction.
- Current functional assessment: an ATP (Assistive Technology Professional) evaluation and a physician face-to-face encounter note documenting your mobility limitation in activities of daily living.
- Medical-necessity letter: your prescribing physician should explicitly state why the requested Group 3 power wheelchair is not duplicative — i.e., how it differs from or supersedes any prior device.
- UHC's coverage policy: obtain UHC's published Medical Policy for power mobility devices and identify the exact language governing the replacement or upgrade criteria.
## Criteria-Mapping Structure
Open UHC's policy and list every criterion it requires to authorize a Group 3 power wheelchair. For each criterion, pull the matching fact from your chart:
| Policy Requirement | Chart Evidence | |---|---| | Mobility limitation in the home | [Physician note + functional assessment date] | | Prior device status (lost/broken/different class) | [Equipment records, repair history, ATP evaluation] | | Replacement interval or changed clinical need | [Progress notes documenting clinical change] |
Present this table in your appeal letter so the reviewer can confirm each requirement is met without hunting through records.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- UnitedHealthcare denied as duplicate or overlapping therapy of ABA Autism
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant Prodrug
- UnitedHealthcare denied as duplicate or overlapping therapy of Anti Amyloid Leqembi